These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25060298)

  • 1. Translational challenges in targeting latent HIV infection and the CNS reservoir problem.
    Garrido C; Margolis DM
    J Neurovirol; 2015 Jun; 21(3):222-6. PubMed ID: 25060298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Eradication Strategies: Implications for the Central Nervous System.
    Veenhuis RT; Clements JE; Gama L
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):96-104. PubMed ID: 30734905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.
    Margolis DM; Archin NM
    J Infect Dis; 2017 Mar; 215(suppl_3):S111-S118. PubMed ID: 28520964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.
    Beck SE; Queen SE; Metcalf Pate KA; Mangus LM; Abreu CM; Gama L; Witwer KW; Adams RJ; Zink MC; Clements JE; Mankowski JL
    J Neurovirol; 2018 Apr; 24(2):204-212. PubMed ID: 28975505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV latency in the humanized BLT mouse.
    Marsden MD; Kovochich M; Suree N; Shimizu S; Mehta R; Cortado R; Bristol G; An DS; Zack JA
    J Virol; 2012 Jan; 86(1):339-47. PubMed ID: 22072769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which therapeutic strategy will achieve a cure for HIV-1?
    Cillo AR; Mellors JW
    Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV reservoirs as obstacles and opportunities for an HIV cure.
    Chun TW; Moir S; Fauci AS
    Nat Immunol; 2015 Jun; 16(6):584-9. PubMed ID: 25990814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.
    Fois AF; Brew BJ
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):299-303. PubMed ID: 25869939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic approaches targeting HIV reservoirs].
    Cheret A
    Virologie (Montrouge); 2019 Aug; 23(4):250-259. PubMed ID: 31414662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
    Churchill MJ; Cowley DJ; Wesselingh SL; Gorry PR; Gray LR
    J Neurovirol; 2015 Jun; 21(3):290-300. PubMed ID: 25060300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of human immunodeficiency virus from brain reservoirs.
    Nath A
    J Neurovirol; 2015 Jun; 21(3):227-34. PubMed ID: 25366659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antivirals: Winning at hide-and-seek with latent HIV reservoirs.
    Cully M
    Nat Rev Drug Discov; 2016 Aug; 15(8):532. PubMed ID: 27444221
    [No Abstract]   [Full Text] [Related]  

  • 14. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA; Blankson JN
    Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.
    Ren Y; Huang SH; Patel S; Alberto WDC; Magat D; Ahimovic D; Macedo AB; Durga R; Chan D; Zale E; Mota TM; Truong R; Rohwetter T; McCann CD; Kovacs CM; Benko E; Wimpelberg A; Cannon C; Hardy WD; Bosque A; Bollard CM; Jones RB
    J Clin Invest; 2020 May; 130(5):2542-2559. PubMed ID: 32027622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV latency reversal agents: A potential path for functional cure?
    Lopes JR; Chiba DE; Dos Santos JL
    Eur J Med Chem; 2021 Mar; 213():113213. PubMed ID: 33540228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
    Grau-Expósito J; Luque-Ballesteros L; Navarro J; Curran A; Burgos J; Ribera E; Torrella A; Planas B; Badía R; Martin-Castillo M; Fernández-Sojo J; Genescà M; Falcó V; Buzon MJ
    PLoS Pathog; 2019 Aug; 15(8):e1007991. PubMed ID: 31425551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial Cells: The Main HIV-1 Reservoir in the Brain.
    Wallet C; De Rovere M; Van Assche J; Daouad F; De Wit S; Gautier V; Mallon PWG; Marcello A; Van Lint C; Rohr O; Schwartz C
    Front Cell Infect Microbiol; 2019; 9():362. PubMed ID: 31709195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV reservoirs and the possibility of a cure for HIV infection.
    Palmer S; Josefsson L; Coffin JM
    J Intern Med; 2011 Dec; 270(6):550-60. PubMed ID: 21929712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.